ArticleVeterinary world2019
Stimulation of non-specific immunity, gene expression, and disease resistance in Nile Tilapia,
Article in Veterinary world, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 20 citations in OpenAlex.
- Biophytum sensitivum: a promising herbal diet supplement for enhancing growth, immune response, antioxidant status, and disease resistance in Nile tilapia (Oreochromis niloticus).Fish physiology and biochemistry · 2026Article
- Characteristics ofHeliyon · 2024Article
- Dietary supplementation ofFish and shellfish immunology reports · 2023Article
- Effects of low-light stress on aquacultural water quality and disease resistance in Nile tilapia.PloS one · 2022Article
- Antimicrobials from Seaweeds for Food Applications.Marine drugs · 2021Review
- Bioinformatic Characterization of Sulfotransferase Provides New Insights for the Exploitation of Sulfated Polysaccharides inInternational journal of molecular sciences · 2020Article
- Ziziphus mauritiana supplementation of Nile tilapia (Oreochromis niloticus) diet for improvement of immune response to Aeromonas hydrophila infection.Fish physiology and biochemistry · 2020Article
- Immune response evaluation inVeterinary world · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe objective of the present study was to test the immunostimulating potential of marine macroalga, MATERIALS AND
methods
resultsCSME increased serum lysozyme, myeloperoxidase, and antiprotease activities. There was an increase in the expression of lysozyme gene in the spleen of treated fish. Mid dose of CSME caused the minimum mortality of 10% (consequent relative percentage survival = 73) which is comparable to that of the positive control.
conclusionCSME is considered to have the potential to be developed into an immunostimulant for finfish aquaculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.